H.Res. 803 — Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

H.Res. 803 — Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes. | JustPolicyThe purpose of this resolution is to urge the Director of the Food and Drug Administration (FDA) to reassess the safety of chemical abortion drugs. This comes in response to recent independent studies that have raised concerns about these medications. The resolution aims to ensure that the FDA takes a closer look at the potential risks associated with these drugs, particularly in light of their increasing use. Key provisions of the resolution include a call for the FDA to reevaluate the safety of all chemical abortion drugs and to publicly share a comprehensive safety review.